Ets-2 and p53 mediate cAMP-induced MMP-2 expression, activity and trophoblast invasion

Reproductive Biology and Endocrinology

Volumn 7, Issue , 2009, Pages

  Staun Ram, Elsebeth ^a,b   Goldman, Shlomit ^a   Shalev, Eliezer ^a,b  

^a HAEMEK MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN LAMBDA; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; GELATINASE A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN P53; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR ETS 2; UNCLASSIFIED DRUG; ETS2 PROTEIN, HUMAN; MMP2 PROTEIN, HUMAN;

ARTICLE; BINDING SITE; CANCER CELL CULTURE; CELL INVASION; CHORIOCARCINOMA; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; ENZYME RELEASE; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TROPHOBLAST; WESTERN BLOTTING; ZYMOGRAPHY; CELL ADHESION; CELL CULTURE; CELL MOTION; DRUG EFFECT; GENE EXPRESSION; GENETICS; METABOLISM; PHYSIOLOGY;

BINDING SITES; CELL ADHESION; CELL MOVEMENT; CELLS, CULTURED; CYCLIC AMP; FORSKOLIN; GENE EXPRESSION; HUMANS; MATRIX METALLOPROTEINASE 2; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEIN C-ETS-2; TROPHOBLASTS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 71649090820     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-7-135     Document Type: Article

References (76)

1. Srisuparp S, Strakova Z, Fazleabas AT. The role of chorionic gonadotropin (CG) in blastocyst implantation. Arch Med Res 2001, 32(6):627-634. 10.1016/S0188-4409(01)00330-7, 11750740.
2. Meisser A, Chardonnens D, Campana A, Bischof P. Effects of tumour necrosis factor alpha, interleukin-1 alpha, macrophage colony stimulating factor and transforming growth factor beta on trophoblastic matrix metalloproteinases. Mol Hum Reprod 1999, 5:252-260. 10.1093/molehr/5.3.252, 10333360.
3. Staun-Ram E, Shalev E. Human trophoblast function during the implantation process. Reprod Biol Endocrinol 2005, 3:56. 10.1186/1477-7827-3-56, 1289292, 16236179.
4. Fisher SJ, Leitch MS, Kantor MS, Basbaum CB, Kramer RH. Degradation of extracellular matrix by the trophoblastic cells of first trimester human placentas. J Cell Biochem 1985, 27:31-41. 10.1002/jcb.240270105, 3980589.
5. Bischof P, Matelli M, Campana A, Itoh Y, Ogata Y, Nagase H. Importance of metalloproteinases in human trophoblast invasion. Early Pregnancy Biology and Medicine 1995, 1(4):263-269.
6. Bischof P, Campana A. Molecular mediators of implantation. Bailliere's Clinical Obstetrics and Gynaecology 2000, 14(5):801-814. 10.1053/beog.2000.0120, 11023801.
7. Librach CL, Werb Z, Fitzgerald ML, Chiu K, Corwin NM, Esteves RA, Grobelny D, Galardy R, Damsky CH. 92-kDa type IV collagenase mediates invasion of human cytotrophoblasts. J Cell Biol 1991, 113:437-449. 10.1083/jcb.113.2.437, 2288933, 1849141.
8. Staun-Ram E, Goldman S, Gabarin D, Shalev E. Expression and importance of matrix metalloproteinases 2 and 9 (MMP-2 and -9) in human trophoblast invasion. Reprod Biol Endocrinol 2004, 2(1):59. 10.1186/1477-7827-2-59, 516041, 15294019.
9. Xu P, Wang Y, Zhu S, Luo S, Piao Y, Zhuang L. Expression of matrix metalloproteinase-2, -9 and -14, tissue inhibitors of metalloproteinse-1, and matrix proteins in human placenta during the first trimester. Biol Reprod 2000, 62:988-994. 10.1095/biolreprod62.4.988, 10727268.
10. Robillard PY. Interest in preeclampsia for researchers in reproduction. Reprod Immunol 2002, 53(1-2):279-287.
11. Smith GC. First trimester origins of fetal growth impairment. Semin Perinatol 2004, 28(1):41-50. 10.1053/j.semperi.2003.10.012, 15058901.
12. Di Simone N, Di Nicuolo F, Sanguinetti M, Ferrazzani S, D'Alessio MC, Castellani R, Bompiani A, Caruso A. Low-molecular weight heparin induces in vitro trophoblast invasiveness: role of matrix metalloproteinases and tissue inhibitors. Placenta 2007, 28(4):298-304. 10.1016/j.placenta.2006.04.001, 16750851.
13. Graham CH, Connelly I, MacDougall JR, Kerbel RS, Stetler-Stevenson WG, Lala PK. Resistance of malignant trophoblast cells to both the anti-proliferative and anti-invasive effects of transforming growth factor-beta. Exp Cell Res 1994, 214(1):93-99. 10.1006/excr.1994.1237, 8082752.
14. Karyer G, Alsat E, Tasken K, Evain-Brion D. Cyclic AMP-dependent protein kinases and human trophoblast cell differentiation in vitro. J Cell Sci 1994, 995-1004.
15. Zygmunt M, Hahn D, Munstedt K, Bischof P, Lang U. Invasion of cytotrophoblastic JEG-3 cells is stimulated by hCG in vitro. Placenta 1998, 19(8):587-593. 10.1016/S0143-4004(98)90019-4, 9859862.
16. Zygmunt M, Herr F, Keller-Schoenwetter S, Kunzi-Rapp K, Munstedt K. Characterization of human chorionic gonadotropin as a novel angiogenic factor. J Clin Endocrinol Metab 2002, 87(11):5290-5296. 10.1210/jc.2002-020642, 12414904.
17. Zygmunt M, McKinnon T, Herr F, Lala PK, Han VK. HCG increases trophoblast migration in vitro via the insulin-like growth factor-II/mannose-6 phosphate receptor. Mol Hum Reprod 2005, 11(4):261-267. 10.1093/molehr/gah160, 15749784.
18. Licht P, Russu V, Wildt L. On the role of human chorionic gonadotropin (hCG) in the embryo-endometrial microenvironment: implications for differentiation and implantation. Semin Reprod Med 2001, 19(1):37-47. 10.1055/s-2001-13909, 11394202.
19. Yamamoto T, Matsumoto K, Kurachi H, Okamoto Y, Nishio Y, Sakata M, Tasaka K, Murata Y. Progesterone inhibits transcriptional activation of human chorionic gonadotropin-alpha through protein kinase A pathway in trophoblast cells. Mol Cell Endocrinol 2001, 182(2):215-224. 10.1016/S0303-7207(01)00580-9, 11514056.
20. Belkacemi L, Beall MH, Magee TR, Pourtemour M, Ross MG. AQP1 gene expression is upregulated by arginine vasopressin and cyclic AMP agonists in trophoblast cells. Life Sci 2008, 82(25-26):1272-1280. 10.1016/j.lfs.2008.04.014, 18538351.
21. Baczyk D, Drewlo S, Proctor L, Dunk C, Lye1 S, Kingdom J. Glial cell missing-1 transcription factor is required for the differentiation of the human trophoblast. Cell Death and Differentiation 2009, 16:719-727. 10.1038/cdd.2009.1, 19219068.
22. Keryer G, Alsat E, Tasken K, Evain-Brion D. Cyclic AMP-dependent protein kinases and human trophoblast cell differentiation in vitro. J Cell Science 1998, 111:995-1004.
23. Fini ME, Cook JR, Mohan R, Brinckerhoff CE. Regulation of matrix metalloproteinase gene expression. Matrix Metalloproteinases 1998, 299-356. San Diego, CA, Academic Press, Parks WC, Mecham RP.
24. Price SJ, Greaves DR, Watkins H. Identification of noval, functional genetic variants in the human matrix metalloproteinase-2 gene. J Biol Chem 2001, 276:7549-7558. 10.1074/jbc.M010242200, 11114309.
25. Qin H, Sun Y, Beneviste EN. The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J Biol Chem 1999, 274(41):29130-29137. 10.1074/jbc.274.41.29130, 10506168.
26. Blaschitz A, Weissb U, Dohra G, Desoye G. Antibody Reaction Patterns in First Trimester Placenta: Implications for Trophoblast Isolation and Purity Screening. Placenta 2000, 21:733-741. 10.1053/plac.2000.0559, 10985978.
27. Ben-Zimra M, Koler M, Orly J. Transcription of Cholesterol Side-Chain Cleavage Cytochrome P450 in the Placenta: Activating Protein-2 Assumes the Role of Steroidogenic Factor-1 by Binding to an Overlapping Promoter Element. Molecular Endocrinology 2002, 16(8):1864-1880. 10.1210/me.2002-0056, 12145340.
28. Bergman MR, Cheng S, Honbo N, Piacentini L, Karliner JS, Lovett DH. A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers. Biochem J 2003, 369(Pt 3):485-496. 10.1042/BJ20020707, 1223099, 12371906.
29. Bischof P, Truong K, Campana A. Regulation of Trophoblastic Gelatinases by Proto-oncogenes. Placenta 2003, 24:155-163. 10.1053/plac.2002.0890, 12566242.
30. Cohen M, Meisser A, Haenggeli L, Irminger-Finger I, Bischof P. Status of p53 in first-trimester cytotrophoblastic cells. Mol Hum Reprod 2007, 13(2):111-116. 10.1093/molehr/gal105, 17158854.
31. Cohen M, Wuillemin C, Bischof P. Trophoblastic p53 is stabilized by a cis-trans isomerisation necessary for the formation of high molecular weight complexes involving the N-terminus of p53. Biochimie 2008, 90(6):855-862. 10.1016/j.biochi.2008.02.006, 18316040.
32. Ghosh D, Ezashi T, Ostrowski MC, Roberts RM. A central role for Ets-2 in the transcriptional regulation and Cyclic Adenosine 5'-Monophosphate responsiveness of the Human Chorionic Gonadotrophin-β subunit gene. Molecular Endocrinology 2003, 17(1):11-26. 10.1210/me.2002-0223, 12511603.
33. Soloveva V, Linzer DI. Differentiation of placental trophoblast giant cells requires downregulation of p53 and Rb. Placenta 2004, 25(1):29-36. 10.1016/S0143-4004(03)00215-7, 15013636.
34. Yamamoto H, Flannery ML, Kupriyanov S, Pearce J, McKercher SR, Henkel GW, Maki RA, Werb Z. Defective trophoblast function in mice with a targeted mutation of Ets2. Genes & Development 1998, 12:1315-1326.
35. Frisch SM, Morisaki JH. Positive and negative transcriptional elements of the human type IV collagenase gene. Mol Cell Biol 1990, 10(12):6524-6532. 362929, 2174109.
36. Bian J, Sun Y. Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter. Mol Cell Biol 1997, 17(11):6330-6338. 232484, 9343394.
37. Zhou WH, Du MR, Dong L, Zhu XY, Yang JY, He YY, Li DJ. Cyclosporin A increases expression of matrix metalloproteinase 9 and 2 and invasiveness in vitro of the first-trimester human trophoblast cells via the mitogen-activated protein kinase pathway. Hum Reprod 2007, 22(10):2743-2750. 10.1093/humrep/dem097, 17566014.
38. MacPhee DJ, Mostachfi H, Han R, Lye SJ, Post M, Caniggia I. Focal adhesion kinase is a key mediator of human trophoblast development. Lab Invest 2001, 81(11):1469-1483.
39. Goldman S, Shalev E. Difference in Progesterone receptor isoforms ratio, between early and late first trimester human trophoblast, is associated with differential cell invasion and matrix metalloproteinase2 (MMP2) expression. Biol Reprod 2006, 74(1):13-22. 10.1095/biolreprod.105.044925, 16135696.
40. Prast J, Saleh L, Husslein H, Sonseregger S, Helmer H, Knöfler M. Human chorionic gonadotrophin stimulates trophoblast invasion through ERK and AKT signaling. Endocrinology 2008, 149(3):979-987. 10.1210/en.2007-1282, 18063683.
41. Oikawa T, Yamada T. Molecular biology of the Ets family of transcription factors. Gene 2003, 16:11-34.
42. Yordy JS, Muise-Helmericks RC. Signal transduction and the Ets family of transcription factors. Oncogene 2000, 19(55):6503-6513. 10.1038/sj.onc.1204036, 11175366.
43. Foulds CE, Nelson ML, Blaszczak AG, Graves BJ. Ras/Mitogen- activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment. Molecular and Cellular Biology 2004, 24(24):10954-10964. 10.1128/MCB.24.24.10954-10964.2004, 533975, 15572696.
44. Wasylyk B, Hagman J, Gutierrez-Hartman A. Ets transcription factors: nuclear effectors of the Ras-Map-kinase signaling pathway. Trends Biochem Sci 1998, 23(6):213-216. 10.1016/S0968-0004(98)01211-0, 9644975.
45. Singh S, Barrett J, Sakata K, Tozer RG, Singh G. ETS proteins and MMPs: partners in invasion and metastasis. Curr Drug Targets 2002, 3(5):259-267. 10.2174/1389450023347489, 12041739.
46. Trojanowska M. Ets factors and regulation of the extracellular matrix. Oncogene 2000, 19(55):6464-6471. 10.1038/sj.onc.1204043, 11175362.
47. Ghosh D, Sachdev S, Hannink M, Roberts RM. Coordinate regulation of basal and Cyclic 5'-Adenosine Monophosphate (cAMP)-activated expression of human chorionic gonadotrophin-α by Ets-2 and cAMP-responsive element binding protein. Mol Endocrinol 2005, 19(4):1049-1066. 10.1210/me.2004-0320, 15637148.
48. Sun Y, Duckworth ML. Identification of a placental specific enhancer in the rat placental lactogen II gene that contains binding sites for members of the Ets and AP1 (activator protein1) families of transcription factors. Mol Endocrinol 1999, 13:385-399. 10.1210/me.13.3.385, 10076996.
49. Pestell RG, Albanese C, Watanabe G, Lee RJ, Lastowiecki P, Zon L, Ostrowski M, Jameson JL. Stimulation of the P-450 side chain cleavage enzyme (CYP11A1) promoter through ras- and Ets-2-signaling pathways. Mol Endocrinol 1996, 10:1084-1094. 10.1210/me.10.9.1084, 8885243.
50. Orwig KE, Soares MJ. Transcriptional activation of the decidual/trophoblast prolactin related protein gene. Endocrinology 1999, 140:4032-4039. 10.1210/en.140.9.4032, 10465273.
51. Buttice G, Duterque-Coquillaud M, Basuyaux JP, Carrere S, Kurkinen M, Stehelin D. Erg, an Ets-family member, differentially regulates human collagenase1 (MMP1) and stromelysin1 (MMP3) gene expression by physically interacting with the Fos/jun complex. Oncogene 1996, 12:2297-2306.
52. Staun-Ram E, Goldman S, Shalev E. p53 Mediates Epidermal Growth Factor (EGF) Induction of MMP-2 Transcription and Trophoblast Invasion. Placenta 2009,
53. El-Deiry WS, Kern S, Pietenpol JA, Kinzler KW, Vogelstein B. Definition of a consensus binding site for p53. Nat Gene 1992, 1(1):45-49.
54. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995, 80(2):293-299. 10.1016/0092-8674(95)90412-3, 7834749.
55. Ludes-Meyers JH, Subler MA, Shivakumar CV, Munoz RM, Jiang P, Bigger JE, Brown DR, Deb SP, Deb S. Transcriptional activation of the human epidermal growth factor receptor promoter by human p53. Mol Cell Biol 1996, 16(11):6009-6019. 231603, 8887630.
56. Donehower LA, Bradley A. The tumor suppressor p53. Biochim Biophys Acta 1993, 1155(2):181-205.
57. Kastan MB, Canman CE, Leonard CJ. P53, cell cycle control and apoptosis: implications for cancer. Cancer Metastasis Rev 1995, 14(1):3-15. 10.1007/BF00690207, 7606818.
58. Ko LJ, Prives C. p53: puzzle and paradigm. Genes Dev 1996, 10(9):1054-1072. 10.1101/gad.10.9.1054, 8654922.
59. Cadwell C, Zambetti GP. The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth. Gene 2001, 277(1-2):15-30. 10.1016/S0378-1119(01)00696-5, 11602342.
60. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994, 54(18):4855-4878.
61. Wells D, Bermudez MG, Steuerwald N, Thornhill AR, Walker DL, Malter H, Delhanty JD, Cohen J. Expression of genes regulating chromosome segregation, the cell cycle and apoptosis during human preimplantation development. Hum Reprod 2005, 20(5):1339-1348. 10.1093/humrep/deh778, 15705620.
62. Jurisicova A, Latham KE, Casper RF, Casper RF, Varmuza SL. Expression and regulation of genes associated with cell death during murine preimplantation embryo development. Mol Reprod Dev 1998, 51:243-253. 10.1002/(SICI)1098-2795(199811)51:3<243::AID-MRD3>3.0.CO;2-P, 9771644.
63. Hickson JA, Fong B, Watson PH, Watson AJ. PP2Cdelta (Ppm1d, WIP1), an endogenous inhibitor of p38 MAPK, is regulated along with Trp53 and Cdkn2a following p38 MAPK inhibition during mouse preimplantation development. Mol Reprod Dev 2007, 74(7):821-834. 10.1002/mrd.20688, 17219434.
64. Komatsu D, Abe T, Sano Y, Shimazaki K, Tomita M, Kanayama N, Takahashi K. Increase of the trophoblast giant cells with prolactin-releasing peptide (PrRP) receptor expression in p53-null mice. Mol Reprod Dev 2007, 74(9):1089-1094. 10.1002/mrd.20505, 17410546.
65. Haidacher S, Blaschitz A, Desoye G, Dohr G. Immunohistochemical evidence of p53 protein in human placenta and choriocarcinoma cell lines. Hum Reprod 1995, 10(4):983-8.
66. Quenby S, Brazeau C, Drakeley A, Lewis-Jones DI, Vince G. Oncogene and tumour suppressor gene products during trophoblast differentiation in the first trimester. Mol Hum Reprod 1998, 4(5):477-481. 10.1093/molehr/4.5.477, 9665634.
67. Marzusch K, Ruck P, Horny HP, Dietl J, Kaiserling E. Expression of the p53 tumour suppressor gene in human placenta: an immunohistochemical study. Placenta 1995, 16(1):101-104. 10.1016/0143-4004(95)90086-1, 7716122.
68. Levy R, Smith SD, Yusuf K, Huettner PC, Kraus FT, Sadovsky Y, Nelson DM. Trophoblast apoptosis from pregnancies complicated by fetal growth restriction is associated with enhanced p53 expression. Am J Obstet Gynecol 2002, 186(5):1056-1061. 10.1067/mob.2002.122250, 12015537.
69. Haezell AE, Lacey HA, Jones CJ, Huppertz B, Baker PN, Crocker IP. Effects of oxygen on cell turnover and expression of regulators of apoptosis in human placental trophoblast. Placenta 2008, 29(2):175-186. 10.1016/j.placenta.2007.11.002, 18155142.
70. Crocker I. Gabor Than Award Lecture (2006): pre-eclampsia and villous trophoblast turnover: perspectives and possibilities. Placenta 2006, 28(Suppl A):4-13.
71. Kale A, Sövlemez F, Ensari A. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease. Am J Obstet Gynecol 2006, 184(4):567-574.
72. Petignat P, Laurini R, Goffins F, Bruchim I, Bischof P. Expression of matrix metalloproteinase-2 and mutant p53 is increased in hydatidiform mole as compared with normal placenta. Int J Gynecol Cancer 2006, 16(4):1679-1684. 10.1111/j.1525-1438.2006.00643.x, 16884384.
73. Cheung AN, Srivastava G, Chung LP, Ngan HY, Man TK, Liu YT, Chen WZ, Collins RJ, Wong LC, Ma HK. Expression of the p53 gene in trophoblastic cells in hydatidiform moles and normal human placentas. J Reprod Med 1994, 39(3):223-227.
74. Fulop V, Mok SC, Genest DR, Gati I, Doszpod J, Berkowitz RS. p53, p21, Rb and mdm2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma. J Reprod Med 1998, 43(2):119-127.
75. Halperin R, Peller S, Sandbank J, Bukovsky I, Schneider D. Expression of the p53 gene and apoptosis in gestational trophoblastic disease. Placenta 2000, 21(1):58-62. 10.1053/plac.1999.0442, 10692252.
76. Cohen M, Wuillemin C, Irion O, bischof P. Regulation of MMP-9 by p53 in first trimester cytotrophoblastic cells. Human Reproduction 2008, 23(10):2273-2281. 10.1093/humrep/den264, 2538584, 18635530.